| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 36 |
| 1 | CLOPIDOGREL | 19 |
| 2 | CLOPIDOGREL BISULFATE | 17 |
| 3 | ASPIRIN | 16 |
| 4 | APIXABAN | 15 |
| 5 | EMICIZUMAB | 15 |
| 6 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 13 |
| 7 | ASPIRIN 325 MG | 13 |
| 8 | ASPIRIN 81 MG | 13 |
| 9 | FUROSEMIDE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) | 1 | 0.0065 |
| 1 | FROVATRIPTAN SUCCINATE | 3 | 0.0038 |
| 2 | ACETYLSALICYCLIC ACID | 1 | 0.0034 |
| 3 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 2 | 0.0018 |
| 4 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 13 | 0.0016 |
| 5 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 4 | 0.0015 |
| 6 | BODY CLEANSER | 1 | 0.0014 |
| 7 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 8 | EMICIZUMAB | 15 | 0.0012 |
| 9 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 50 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 3 | Benzodiazepine [EPC] | 15 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 15 |
| 5 | Corticosteroid [EPC] | 14 |
| 6 | Vitamin C [EPC] | 14 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | Proton Pump Inhibitor [EPC] | 11 |
| 9 | Endothelin Receptor Antagonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Antihemophilic Factor [EPC] | 1 | 0.0065 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 2 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 7 | Human Immunoglobulin G [EPC] | 4 | 0.0002 |
| 8 | Factor Xa Inhibitor [EPC] | 50 | 0.0002 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |